Literature DB >> 21787760

Understanding SOS (Son of Sevenless).

Stéphane Pierre1, Anne-Sophie Bats, Xavier Coumoul.   

Abstract

Son of Sevenless (SOS) was discovered in Drosophila melanogaster. Essential for normal eye development in Drosophila, SOS has two human homologues, SOS1 and SOS2. The SOS1 gene encodes the Son of Sevenless 1 protein, a Ras and Rac guanine nucleotide exchange factor. This protein is composed of several important domains. The CDC25 and REM domains provide the catalytic activity of SOS1 towards Ras and the histone fold DH/PH (Dbl homology and Pleckstrin homology) domains function, in tandem, to stimulate GTP/GDP exchange for Rac. In contrast to Ras, there have been few studies that implicate SOS1 in human disease and, initially, less attention was given to this gene. However, mutations in SOS1 have been reported recently in Noonan syndrome and in type 1 hereditary gingival fibromatosis. Although, there have been very few studies that focus on the regulation of this important gene by physiological or exogenous factors, we recently found that the SOS1 gene was induced by the environmental toxin, dioxin, and that this effect was mediated by the aryl hydrocarbon receptor (AhR). These recent observations raise the possibility that alterations in the expression of the SOS1 gene and, consequently, in the activity of the SOS1 protein may affect toxicological endpoints and lead to clinical disease. These possibilities, thus, have stimulated much interest in SOS1 recently. In this article, we review the functions of SOS1 and the evidence for its roles in physiology and pathology across species.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21787760     DOI: 10.1016/j.bcp.2011.07.072

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  27 in total

1.  Rational design of small molecule inhibitors targeting the Ras GEF, SOS1.

Authors:  Chris R Evelyn; Xin Duan; Jacek Biesiada; William L Seibel; Jaroslaw Meller; Yi Zheng
Journal:  Chem Biol       Date:  2014-11-20

2.  Combined rational design and a high throughput screening platform for identifying chemical inhibitors of a Ras-activating enzyme.

Authors:  Chris R Evelyn; Jacek Biesiada; Xin Duan; Hong Tang; Xun Shang; Ruben Papoian; William L Seibel; Sandra Nelson; Jaroslaw Meller; Yi Zheng
Journal:  J Biol Chem       Date:  2015-03-30       Impact factor: 5.157

3.  Differential allelic expression of SOS1 and hyperexpression of the activating SOS1 c.755C variant in a Noonan syndrome family.

Authors:  Silvia Moncini; Maria Teresa Bonati; Ilaria Morella; Luca Ferrari; Riccardo Brambilla; Paola Riva
Journal:  Eur J Hum Genet       Date:  2015-02-25       Impact factor: 4.246

4.  Allosteric KRas4B Can Modulate SOS1 Fast and Slow Ras Activation Cycles.

Authors:  Tsung-Jen Liao; Hyunbum Jang; David Fushman; Ruth Nussinov
Journal:  Biophys J       Date:  2018-07-24       Impact factor: 4.033

5.  Identification of key genes associated with the effect of osmotic stimuli on intervertebral discs using microarray analysis.

Authors:  Guangxiao Ni; Guobin Liu; Kunlun Yu
Journal:  Oncol Lett       Date:  2017-07-24       Impact factor: 2.967

6.  Sequence analysis of the Ras-MAPK pathway genes SOS1, EGFR & GRB2 in silver foxes (Vulpes vulpes): candidate genes for hereditary hyperplastic gingivitis.

Authors:  Jo-Anna B J Clark; Sara J Tully; H Dawn Marshall
Journal:  Genetica       Date:  2014-11-07       Impact factor: 1.082

7.  Structural landscape of the proline-rich domain of Sos1 nucleotide exchange factor.

Authors:  Caleb B McDonald; Vikas Bhat; Dmitry Kurouski; David C Mikles; Brian J Deegan; Kenneth L Seldeen; Igor K Lednev; Amjad Farooq
Journal:  Biophys Chem       Date:  2013-03-05       Impact factor: 2.352

8.  Molecular origin of the binding of WWOX tumor suppressor to ErbB4 receptor tyrosine kinase.

Authors:  Brett J Schuchardt; Vikas Bhat; David C Mikles; Caleb B McDonald; Marius Sudol; Amjad Farooq
Journal:  Biochemistry       Date:  2013-12-13       Impact factor: 3.162

9.  EGF receptor uses SOS1 to drive constitutive activation of NFκB in cancer cells.

Authors:  Sarmishtha De; Josephine Kam Tai Dermawan; George R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-28       Impact factor: 11.205

Review 10.  Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.

Authors:  Patricio Godoy; Nicola J Hewitt; Ute Albrecht; Melvin E Andersen; Nariman Ansari; Sudin Bhattacharya; Johannes Georg Bode; Jennifer Bolleyn; Christoph Borner; Jan Böttger; Albert Braeuning; Robert A Budinsky; Britta Burkhardt; Neil R Cameron; Giovanni Camussi; Chong-Su Cho; Yun-Jaie Choi; J Craig Rowlands; Uta Dahmen; Georg Damm; Olaf Dirsch; María Teresa Donato; Jian Dong; Steven Dooley; Dirk Drasdo; Rowena Eakins; Karine Sá Ferreira; Valentina Fonsato; Joanna Fraczek; Rolf Gebhardt; Andrew Gibson; Matthias Glanemann; Chris E P Goldring; María José Gómez-Lechón; Geny M M Groothuis; Lena Gustavsson; Christelle Guyot; David Hallifax; Seddik Hammad; Adam Hayward; Dieter Häussinger; Claus Hellerbrand; Philip Hewitt; Stefan Hoehme; Hermann-Georg Holzhütter; J Brian Houston; Jens Hrach; Kiyomi Ito; Hartmut Jaeschke; Verena Keitel; Jens M Kelm; B Kevin Park; Claus Kordes; Gerd A Kullak-Ublick; Edward L LeCluyse; Peng Lu; Jennifer Luebke-Wheeler; Anna Lutz; Daniel J Maltman; Madlen Matz-Soja; Patrick McMullen; Irmgard Merfort; Simon Messner; Christoph Meyer; Jessica Mwinyi; Dean J Naisbitt; Andreas K Nussler; Peter Olinga; Francesco Pampaloni; Jingbo Pi; Linda Pluta; Stefan A Przyborski; Anup Ramachandran; Vera Rogiers; Cliff Rowe; Celine Schelcher; Kathrin Schmich; Michael Schwarz; Bijay Singh; Ernst H K Stelzer; Bruno Stieger; Regina Stöber; Yuichi Sugiyama; Ciro Tetta; Wolfgang E Thasler; Tamara Vanhaecke; Mathieu Vinken; Thomas S Weiss; Agata Widera; Courtney G Woods; Jinghai James Xu; Kathy M Yarborough; Jan G Hengstler
Journal:  Arch Toxicol       Date:  2013-08-23       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.